Health Trials

Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration

1

Review clinical trials related to Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors

This is a first-in-human Phase I, multi-center, open-label study of ANS03 in patients with advanced solid tumors. The study evaluates the safety, tolerability, preliminary efficay, pharmacokinetics, anti-tumor activity of ANS03 as monotherapy.

Participants needed: 96
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Avistone Biotechnology Co., Ltd.Updated: Mar 13, 2026Locations: 5
Eligibility criteria

Age ≥ 18 years [+5]

Active infection including tuberculosis and HBV, HCV or HIV [+3]

Read more